title: Severe atopic dermatitis accompanied by autoimmune retinopathy.
authors.forename: Takashi
authors.initials: T
authors.lastname: Nomura
authors.forename: Tomoko
authors.initials: T
authors.lastname: Kayama
authors.forename: Emi
authors.initials: E
authors.lastname: Okamura
authors.forename: Ken
authors.initials: K
authors.lastname: Ogino
authors.forename: Akihito
authors.initials: A
authors.lastname: Uji
authors.forename: Nagahisa
authors.initials: N
authors.lastname: Yoshimura
authors.forename: Takanobu
authors.initials: T
authors.lastname: Kikuchi
authors.forename: Akihiro
authors.initials: A
authors.lastname: Fujisawa
authors.forename: Miki
authors.initials: M
authors.lastname: Tanioka
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Miyachi
authors.forename: Kenji
authors.initials: K
authors.lastname: Kabashima
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000150:complications* / Q000188:drug therapy; D003876:Dermatitis, Atopic / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D012164:Retinal Diseases / Q000150:complications* / Q000188:drug therapy
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D008776:Methylprednisolone Hemisuccinate; D011239:Prednisolone